We are a novel ablation company committed to health innovation using our patented Nano-pulse Stimulation ( NPS ) technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to nonthermally clear or kill targeted cells. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation ( nsPFA …
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$1M
Net Income (TTM)
-$80M
▼ -35.8% YoY
Op. Margin
-7007.76%
ROIC
-71.21%
▼ -7.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$61M
▼ -49.3% YoY
Op. Cash Flow (TTM)
-$61M
▼ -48.9% YoY
Net Debt
-$95M
Net Cash Position
Cash & Equiv.
$102M
Continue Research
Peers
Surgical & Medical Instruments & Apparatus · Pick stocks to compare with PLSE
Held by ETFs
PLSE is in 20 US ETFs. The largest of them, with PLSE's weight in each:
Pulse Biosciences (PLSE) in four numbers
Questions about Pulse Biosciences
Is Pulse Biosciences (PLSE) overvalued?
At $57.06, Pulse Biosciences' price is 162577% above the $0.04 a share fair value that Intrinsiqq's calculator gets from its revenue. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.
What is Pulse Biosciences' fair value?
Intrinsiqq's calculator puts Pulse Biosciences' fair value at $0.04 a share. It grows revenue per share 0% a year for 5 years, applies an exit P/S of 3.4, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $0.03. Every input can be changed on the Intrinsic Value tab.
Is Pulse Biosciences a high-quality business?
Pulse Biosciences scores 40 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 6 checks computed from SEC filings. Its best check is revenue growth at 14.1%, and its weakest is return on capital at -71.2%. The Quality tab shows every check against its target.
Does Pulse Biosciences (PLSE) pay a dividend?
No. Pulse Biosciences (PLSE) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 31 Jul 2026 (period ending 30 Jun 2026), SEC. Price: last close 4 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in PLSE's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing PLSE
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.